“This is a historic day for science…and for all of us,” said the Greek CEO of Pfizer, Albert Bourla, on Friday after the pharmaceuticals giant submitted the Covid-19 vaccine to the FDA for Emergency Use Authorization.
The vaccine, a collaboration between the BioNTech Group and Pfizer, was found to be 95 percent effective at preventing Covid-19 in a late-stage trial.
The FDA has said that it might take weeks to review the vaccine before it will decide to give authorization.
Dr. Bourla said in a video tweet that it took 248 days from the day Pfizer decided to start work with BioNTech to develop and test the vaccine until the day it was submitted to the FDA.
— Pfizer Inc. (@pfizer) November 20, 2020
The Pfizer CEO said that the main focus of the two companies throughout the process was safety. It took thousands of strenuous hours of development work in laboratories and thousands of brave volunteers around the world who tried the vaccine.
The vaccine was submitted to the FDA for authorization and also submitted to Europe, Canada, Australia, Japan, and the United Kingdom for authorization.
Upon approval, the company is ready to manufacture worldwide and ship 50 million doses by the end of the year and 1.3 billion in 2021.
At the end of the short video above the Greek CEO thanks volunteers, scientists, colleagues, and universities around the world who work day and night to help ensure “that science will win”.